A human study for investigating effects of Lycium barbarum extract consumption on antioxidative capacity in hypercholesterolemic adults : a randomized, double-blind, placebo-controlled study

Ewha Womans University0 个研究点目标入组 54 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1) Subject who voluntarily agrees to participate and signs in informed consent form
•2) Age: = 30 years
•3) BMI: = 23kg/m2 and < 30kg/m2
•4) Plasma LDL cholesterol levels = 130mg/dl

•1) Continuous consumption of dietary supplements or medicine which can affect antioxidative capacity within 4 weeks before the first visit
•2) Continuous consumption of Lycium barbarum within 4 weeks before the first visit
•3) Continuous administration of drugs which can affect antioxidative capacity within 4 weeks before the first visit (hypolipidemic, antiinflammatory drug, hypotensive, antibiotics, aspirin, hypoglycemic, anticoagulant)
•4) Subject with following diseases and past medical history within 2 years before the first visit (Hypertension, diabetes, atherosclerosis, chronic inflammatory disease, CVD, renal disease, liver disease, thyroid disease, malignant tumor, mental illness)
•5) Subject who loses weight over 4kg within 30 day before the first visit
•6) Consumption of alcohol (= 140g/week)
•7) Smoker (= 10 cigarettes/day)
•8) Excessive exercise (= 7 hours/week)
•9) Pregnant women, lactating women, or menopausal women with hormone therapy
•10) Participation in other human study within 4 weeks before the first visit
•11) Subjects with hypersensitivity to test materials
•12) Any condition that the principal investigator believes may put the subjects at undue risk

发起方